Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FE1DV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $339,412
Award facts
- Contract value 100% obligated
- $339,412.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $339,412.47 to AmerisourceBergen Drug Corp for the supply of Wegovy (semaglutide) 0.25 mg/0.5 mL pen injections. This firm fixed-price delivery order, issued on September 25, 2025, with a completion date of September 26, 2025, represents a non-set-aside, competitively awarded procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical vendor with an extensive portfolio of drug deliveries to military and veteran healthcare systems. The company's federal contracting activity demonstrates consistent capability in fulfilling diverse pharmaceutical procurement requirements through open competition, ranging from specialty medications to brand-name and generic drugs supporting multiple therapeutic domains. This Wegovy procurement aligns with the company's established role as a prime vendor for the Defense Health Agency and other government healthcare systems under the DLA Troop Support Medical framework.
Quick answers
Who was awarded contract SPE2DB25FE1DV?
SPE2DB25FE1DV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FE1DV worth?
The government has obligated $339,412 on SPE2DB25FE1DV.
Is contract SPE2DB25FE1DV an order under another contract?
Yes. SPE2DB25FE1DV is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1DV competed?
The extent of competition for SPE2DB25FE1DV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award